Healthcare Jul 14, 2021 09:22 AM (GMT+8) · EqualOcean
Recently, Juyi technology announced the completion of round B financing of more than 100 million yuan, which is jointly led by Junlian capital and Yuansheng venture capital, followed by Huagai capital and Taiyu investment, and continued by the old shareholder Sinopharm capital. This round of financing will be used to accelerate the cdmo capacity-building of medical devices and the layout of medical industry transformation, and promote the further development of related businesses. According to reports, Juyi technology is a leading cdmo technology service and product solution platform for medical devices in China, and is committed to providing a series of all-round entrusted product R & D, registration, clinical and entrusted production services for global medical devices, biomedical enterprises and clinical institutions. The scope of service runs through the whole process of device innovation concept and technology research, product cooperative research and development, supply chain management, to commissioned production, product clinical, registration and product listing. Regarding the acquisition of this round of financing, Mr. Cao Changqing, general manager of Juyi technology, said: "the goal of Juyi technology is to grow into a world-class medical device product service technology platform, enabling innovative medical devices, biomedical enterprises, clinical and research institutions, continuously developing and innovating reliable medical device technologies and products, and growing together with customers, Promote the development of China's medical device cdmo industry. After the completion of this round of financing, Juyi technology will further strengthen the construction of technology platform, system construction and capacity expansion, explore more efficient ways of medical research and production transformation, and work with customers to promote more innovative medical device products to clinical application and benefit patients. "